Thyroid eye disease (TED) therapy Tepezza – the top asset in Amgen's $26 billion takeover of Horizon in 2023 – could be facing competition from an easier-to-dose alternative from Sling Therapeutics.

TV and home video editor Ty Pendlebury joined CNET Australia in 2006, and moved to New York City to be a part of CNET in 2011. He tests, reviews and writes about the latest TVs and audio equipment.

Even if you have a comprehensive cable package, streaming services have become all but necessary to keep up with select sports and original TV shows. Fortunately, there are deals on nearly every ...